Pfizer Inc

Morgan Stanley calls for a 26% gain in this under-the-radar ‘safe port in the storm’
Morgan Stanley says investors looking for a hideout in this volatile market should consider putting their money in this lesser known biotechnology stock. Analyst Andrew Galler initiated coverage of Halozyme Therapeutics with an overweight rating and a $50 price target, calling the company a “safe port in a storm.” “Given the macro backdrop, we view […]
Read More
Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in the U.S. Health officials have suggested this is likely to become a new pattern, joining the annual ritual of the flu shot. “For the first […]
Read More
New omicron boosters are now available, but it’s unclear how effective they will be
The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations this fall. But it’s unclear how much protection the new booster shots will provide. The Food and Drug Administration and the Centers for Disease Control and Prevention cleared the shots […]
Read More
CDC panel recommends new omicron Covid boosters with shots expected to begin next week
Justin Sullivan | Getty Images The Centers for Disease Control and Prevention’s independent committee on vaccines recommended reformulated booster shots that target the latest omicron subvariants. The panel voted 13 to 1 Thursday in favor of the shots after reviewing the available safety and effectiveness data in an almost seven-hour-long meeting. CDC Director Dr. Rochelle […]
Read More
U.S. health officials brace for another fall Covid surge, but with fewer deaths
People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City. Liao Pan | China News Service | Getty Images Fall is on the horizon and public health officials are again bracing for another wave of Covid cases. Over the past two years, fall and winter have brought devastating […]
Read More
Moderna sues Pfizer/BioNTech for patent infringement about Covid vaccine
The Moderna Covid-19 vaccine awaits administration at a vaccination clinic in Los Angeles, California on December 15, 2021. Frederic J. Brown | AFP | Getty Visuals Moderna is suing Pfizer and its German spouse BioNTech for patent infringement in the enhancement of the initial Covid-19 vaccine permitted in the United States, alleging they copied technologies […]
Read More
FDA plans to authorize bivalent boosters by Labor Day, sources say
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves Pfizer/BioNTech the COVID-19 coronavirus vaccine for emergency use in the US, reportedly by media. Pavlo Gonchar | AP The Food and Drug Administration plans to […]
Read More
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves Pfizer/BioNTech the COVID-19 coronavirus vaccine for emergency use in the US, reportedly by media. Pavlo Gonchar | AP Pfizer and its German partner BioNTech on […]
Read More
FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17
A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Bloomberg | Bloomberg | Getty Images Biotechnology company Novavax announced on Friday that its Covid-19 vaccine has been authorized for emergency use by the U.S Food and Drug Administration for adolescents between the ages of […]
Read More